Reform bill a preview of BIO agenda

WASHINGTON - Rep. Jon Fox, R-Penn., a member of the Committee on Government Reform and Oversight, plans to introduce an FDA reform bill this week that would limit the agency's ability to require construction of full-scale manufacturing facilities for biologicals prior to approval, instructs FDA to develop guidelines for